tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Tango Therapeutics announces first patient dosed in TNG456 Phase 1/2 trial
PremiumThe FlyTango Therapeutics announces first patient dosed in TNG456 Phase 1/2 trial
2M ago
Tango Therapeutics: Promising Developments and Strategic Focus Justify Buy Rating
Premium
Ratings
Tango Therapeutics: Promising Developments and Strategic Focus Justify Buy Rating
3M ago
Tango Therapeutics Extends Cash Runway Amid Clinical Progress
Premium
Company Announcements
Tango Therapeutics Extends Cash Runway Amid Clinical Progress
3M ago
Tango Therapeutics: Promising Efficacy and Strategic Expansion Justify Buy Rating
PremiumRatingsTango Therapeutics: Promising Efficacy and Strategic Expansion Justify Buy Rating
5M ago
Tango Therapeutics Advances Cancer Treatment Pipeline
Premium
Company Announcements
Tango Therapeutics Advances Cancer Treatment Pipeline
5M ago
Tango Therapeutics reports Q4 EPS (35c), consensus (34c)
Premium
The Fly
Tango Therapeutics reports Q4 EPS (35c), consensus (34c)
5M ago
Tango Therapeutics price target lowered to $8 from $18 at Guggenheim
PremiumThe FlyTango Therapeutics price target lowered to $8 from $18 at Guggenheim
9M ago
Tango Therapeutics Advances Cancer Treatment Pipeline
Premium
Company Announcements
Tango Therapeutics Advances Cancer Treatment Pipeline
9M ago
Trump Media, broader market surge after Trump wins election: Morning Buzz
Premium
The Fly
Trump Media, broader market surge after Trump wins election: Morning Buzz
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100